The Role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study. Radiol Oncol. 2024;58(3):335-347. Accessed September 21, 2026. https://www.radioloncol.com/index.php/ro/article/view/4413